主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADMA
#1299
ADMA Biologics, Inc.
15.5
7
+5.49%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.49%
每月变动
-5.98%
6个月变化
-10.05%
年变化
+1.43%
前一天收盘价
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
交易量
204
市场
股票
医疗保健
ADMA
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Q4 每股收益 超出预期, 营收 低于预期
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
ADMA Biologics即将公布财报:能否实现高目标?
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Adma Biologics总裁Adam Grossman出售价值337,679美元的股票
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note